News Listing

Filter by
Date
MEDIA RELEASE: May 11, 2017 12:05 AM

Proteins on the loose in a debilitating childhood disease

Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).

May 05, 2017 11:00 AM

The path to understanding Parkinson’s disease

Ask any navigator: to get anywhere, it helps to consult a map. And if you don’t have a map, make one.

MEDIA RELEASE: Apr 11, 2017 12:53 PM

Mapping the genome of prostate cancer uncovers a new world o...

Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens th...

MEDIA RELEASE: Apr 11, 2017 05:45 AM

World Parkinson's Day: “Fish with Parkinson’s” uncover a dru...

Australian scientists have developed a first-of-its-kind model of Parkinson’s disease in zebrafish. In the model, neurodegeneration occurs through a combination of genetic and environmental factors – just as it does in p...

MEDIA RELEASE: Apr 07, 2017 02:00 AM

“The best tool of its kind in the world”: Patient Archive be...

Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.

MEDIA RELEASE: Apr 06, 2017 04:00 AM

A one-two punch for pancreatic cancer: ‘softening’ tumours b...

Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy. The findings are published t...

MEDIA RELEASE: Dec 16, 2016 09:00 AM

Genomes of healthy older Australians to accelerate medical r...

Information about the genome sequence of 1200 of Australia’s healthy older people has been made available to medical researchers worldwide, with the launch of the Medical Genome Reference Bank today by Garvan and NSW Hea...

Nov 29, 2016 12:52 PM

Know Your Bones reaches milestone – and scoops national awar...

Know Your Bones, an online bone health self-assessment tool established by Garvan and Osteoporosis Australia, reached 50,000 website visits this month, and received a Highly Commended award at the prestigious National PR...

Nov 25, 2016 05:14 PM

Paspaley’s Kimberley Bracelet for cancer research

Paspaley recently released the 'Kimberley Bracelet' to support Garvan’s cancer research. 25% of the purchase price is donated to Garvan, with Paspaley customers choosing which area of cancer research to support.

MEDIA RELEASE: Nov 10, 2016 09:00 PM

Die Another Day: how the immune system keeps ‘traitor cells’...

Australian researchers have uncovered how our immune system strikes a balance between attacking invaders and leaving our own tissues alone – and, in the process, have solved a 50-year mystery surrounding the role of an e...

Nov 04, 2016 08:00 AM

Kidney disease: whole genome sequencing holds the key to che...

Research from Garvan and St Vincent’s Hospital has shown that whole genome sequencing has the potential to transform the diagnosis of a common inherited kidney disease.

MEDIA RELEASE: Oct 20, 2016 12:01 PM

New Osteoporosis National Action Plan Sets Out Vision to Tac...

Action Plan Calls For National Strategy For Research Into Curing Osteoporosis And To Combat The Burden Of Fractures

MEDIA RELEASE: Oct 14, 2016 09:35 PM

Outwitting the ‘silent thief’: how clues in our genes could ...

In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis. The findings, which arise from Australia’s globally recognised ...

Sep 08, 2016 09:29 AM

‘Forgotten molecule’ takes centre stage in cancer gene silen...

Research from Garvan’s Genomics and Epigenetics Division has shed new light on how genes are silenced in cancer. The findings reveal how DNA becomes chemically decorated (methylated) at key sites across the genome in can...

Aug 26, 2016 03:03 PM

Unravelling the complexity of human immune disease gene by g...

In a series of recent studies, researchers from Garvan’s Immunology Division have shed light on the underlying biology disease in individuals suffering primary immunodeficiencies. Their findings have implications for pat...

MEDIA RELEASE: Aug 09, 2016 01:05 AM

Navigating the human genome with Sequins

Australian genomics researchers have announced the development of Sequins – synthetic ‘mirror’ DNA sequences that reflect the human genome. This intuitive new technology, which can be used to better map and analyse compl...

MEDIA RELEASE: Aug 05, 2016 08:35 AM

Beyond ‘single-gene thinking’: Garvan researchers uncover co...

In a landmark multi-country study, Australian researchers have transformed our understanding of the genes that affect our risk of cancer.

MEDIA RELEASE: Jul 19, 2016 12:05 AM

Grandpa's obesity can affect the health of his grandchildren...

Scientists at Sydney’s Victor Chang Institute and Garvan Institute of Medical Research have discovered that male mice who are obese when they conceive are putting their children and grandchildren at significant risk of d...

MEDIA RELEASE: Jul 13, 2016 05:00 AM

Why artificial sweeteners can increase appetite

Studies in both animals and humans have suggested that consuming artificial sweeteners can make you feel hungry and actually eat more. A comprehensive new study by Sydney researchers has revealed for the first time why t...

Jun 16, 2016 12:40 PM

Know Your Bones: new online bone health assessment tool laun...

Garvan and Osteoporosis Australia are today delighted to announce the launch of Know Your Bones, a freely available online tool that helps consumers to understand their own risk of bone fracture.

Jun 06, 2016 11:43 AM

A 3D view of the cancer genome

Researchers from Garvan's Genomics and Epigenetics Division have shown, for the first time, how the three-dimensional structural organisation of the genome is altered in cancer cells.